rs778172350
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1
The NM_001267550.2(TTN):c.11183dupG(p.Leu3729ThrfsTer9) variant causes a frameshift change. The variant allele was found at a frequency of 0.000304 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.11183dupG | p.Leu3729ThrfsTer9 | frameshift_variant | Exon 46 of 363 | ENST00000589042.5 | NP_001254479.2 | |
TTN | NM_133379.5 | c.10303+2691dupG | intron_variant | Intron 44 of 45 | ENST00000360870.10 | NP_596870.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.11183dupG | p.Leu3729ThrfsTer9 | frameshift_variant | Exon 46 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 | ||
TTN | ENST00000360870.10 | c.10303+2691dupG | intron_variant | Intron 44 of 45 | 5 | NM_133379.5 | ENSP00000354117.4 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000105 AC: 26AN: 248776Hom.: 0 AF XY: 0.0000815 AC XY: 11AN XY: 134932
GnomAD4 exome AF: 0.000318 AC: 465AN: 1461510Hom.: 0 Cov.: 33 AF XY: 0.000283 AC XY: 206AN XY: 727048
GnomAD4 genome AF: 0.000164 AC: 25AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74488
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
TTN: PVS1:Moderate, PS4:Supporting -
c.10670dupG: p.Leu3558ThrfsX9 (L3558TfsX9) in exon 44 of the TTN gene (#NM_133437.3). The normal sequence with the base that is duplicated in braces is: CAAG{G}ACTA. The c.10670dupG variant has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. This variant causes a shift in reading frame starting at codon Leucine 3558, changing it to a Threonine, and creating a premature stop codon at position 9 of the new reading frame, denoted p.Leu3558ThrfsX9. This variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. However, c.10670dupG is located in an alternate transcript of the TTN gene where no disease-causing mutations have been reported.With the clinical and molecular information available at this time, we cannot definitively determine if c.10670dupG is a disease-causing mutation or a rare benign variant. The variant is found in DCM-CRDM panel(s). -
Primary dilated cardiomyopathy Uncertain:2
This TTN truncating variant (TTNtv) was identified in one individual in this cohort and is located in an exon with low levels of cardiac expression. In the seven cohorts assessed, TTNtv were found in 14% of ambulant DCM, 22% end-stage or familial DCM, and 2% controls. Heterozygous nonsense, frameshift and canonical splice-disrupting variants found in constitutive and other highly utilised exons are highly likely to be pathogenic when identified in individuals with phenotypically confirmed DCM. TTNtv found incidentally in healthy individuals (excluding familial assessment of DCM relatives) are thought to have low penetrance, particularly when identified in exons that are not constitutively expressed in the heart. -
This TTN truncating variant (TTNtv) was identified in one individual in this cohort and is located in an exon with low levels of cardiac expression. In the seven cohorts assessed, TTNtv were found in 14% of ambulant DCM, 22% end-stage or familial DCM, and 2% controls. Heterozygous nonsense, frameshift and canonical splice-disrupting variants found in constitutive and other highly utilised exons are highly likely to be pathogenic when identified in individuals with phenotypically confirmed DCM. TTNtv found incidentally in healthy individuals (excluding familial assessment of DCM relatives) are thought to have low penetrance, particularly when identified in exons that are not constitutively expressed in the heart. -
not specified Uncertain:1
Variant summary: TTN c.10303+2691dupG is located at a position not widely known to affect splicing. This variant corresponds to c.11183dupG, p.Leu3729ThrfsX9 in NM_001267550. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. Loss of function variants in all TTN bands are strongly associated with a spectrum of autosomal recessive titinopathies when exon expression (proportion spliced in, PSI, 1=complete expression) in skeletal muscle is >0.1 (PMID: 36977548, 39198997, 29598826, 32778822, 29691892, 33449170, 36977548, internal data). In contrast, loss of function variants in all TTN bands are only strongly associated with autosomal dominant TTN-related cardiomyopathies if located in exons constitutively expressed (PSI >0.9) in cardiac muscle, excluding extreme C-terminal exons 359-363 (PMID: 25589632, 31216868, 32964742, 34662387, 27869827, Shetty et al., Nat Cardiovasc Res 2024, cardiodb.org, internal data). This variant has a maximum skeletal muscle PSI of 0.001 and a maximum cardiac muscle PSI of 0.040. The variant allele was found at a frequency of 0.0001 in 248776 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in TTN causing Autosomal Dominant dilated cardiomyopathy (0.0001 vs 0.00039), allowing no conclusion about variant significance. This variant has been reported in the literature in a variety of settings, such as in controls and individuals with heart failure from the UK biobank cohort (example, Choi_2020), one Dilated Cardiomyopathy (DCM) proband from a cohort that underwent reverse-parent offspring analysis (example, Jansen_2019), in one individual from a cohort of patients with early-onset artial fibrillation (example, Yoneda_2021). These reports do not provide unequivocal conclusions about association of the variant with TTN-related conditions. At-least one co-occurrence with another pathogenic variant has been reported in an individual from a cohort with early-onset Atrial Fibrillation (AF diagnosed before the age of 66 years)(Yoneda_2021, MYH7 c.1988G>A, p.Arg663His), although the specific clinical details were not reported. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31112426, 31691645, 34495297). ClinVar contains an entry for this variant (Variation ID: 202507). Based on the evidence outlined above and the lack of clinical evidence in a low PSI exon, the variant was classified as uncertain significance. -
Cardiomyopathy Uncertain:1
- -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1838244:Tibial muscular dystrophy;C1858763:Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9;C1863599:Myopathy, myofibrillar, 9, with early respiratory failure;C2673677:Early-onset myopathy with fatal cardiomyopathy Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at